256 related articles for article (PubMed ID: 16908018)
1. The immunophenotype of pre-TALL/LBL revisited.
Lewis RE; Cruse JM; Sanders CM; Webb RN; Tillman BF; Beason KL; Lam J; Koehler J
Exp Mol Pathol; 2006 Oct; 81(2):162-5. PubMed ID: 16908018
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
4. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias.
Suggs JL; Cruse JM; Lewis RE
Exp Mol Pathol; 2007 Dec; 83(3):471-3. PubMed ID: 17963747
[TBL] [Abstract][Full Text] [Related]
5. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of T-cell markers in acute myeloid leukemia.
Lewis RE; Cruse JM; Sanders CM; Webb RN; Suggs JL
Exp Mol Pathol; 2007 Dec; 83(3):462-3. PubMed ID: 17927977
[TBL] [Abstract][Full Text] [Related]
7. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
8. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
[TBL] [Abstract][Full Text] [Related]
11. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype.
Babusíková O; Tomová A
Neoplasma; 2002; 49(5):312-8. PubMed ID: 12458329
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
[TBL] [Abstract][Full Text] [Related]
14. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
16. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
17. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
18. The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK+ anaplastic large cell lymphomas.
Bovio IM; Allan RW
Am J Clin Pathol; 2008 Oct; 130(4):628-34. PubMed ID: 18794057
[TBL] [Abstract][Full Text] [Related]
19. Cross-lineage expression in 505 patients with acute lymphoblastic leukemia by multiparametric flow cytometry analysis.
Wang XB; Du W; Xia L; Zheng JE; Liu J; He YL; Sun ZM; Huang SA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1419-23. PubMed ID: 20030918
[TBL] [Abstract][Full Text] [Related]
20. Shifts in expression of immunological cell markers in relapsed acute leukemia.
Tomová A; Babusíková O
Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]